This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
This study is connected with Asian TAVR registry(NCT02308150). Some subjects from Asian TAVR registry continue 10 years follow-up on this TP-TAVR registry.
Study Type
OBSERVATIONAL
Enrollment
10,000
transcatheter aortic valve replacement (TAVR)
Stanford University
Stanford, California, United States
RECRUITINGNorthwestern Memorial Hospital
Chicago, Illinois, United States
RECRUITINGSecond Affiliated Hospital of Zhejiang University
Hangzhou, China
Event rate of all cause death
Time frame: 1 year
Event rate of cardiovascular death
A. Death due to proximate cardiac cause B. Death caused by non-coronary vascular condition C. All procedure-related death D. All valve-related death E. Sudden or unwitnessed death F. Death of unknown cause
Time frame: 10 years
Event rate of myocardial infarction
according to Valve Academic Research Consortium (VARC) criteria
Time frame: 10 years
Event rate of cerebrovascular accident
stroke and TIA (Transient Ischemic Attack)
Time frame: 10 years
Event rate of bleeding
according to Valve Academic Research Consortium (VARC) criteria
Time frame: 10 years
Event rate of Vascular access site and access-related complication
according to Valve Academic Research Consortium (VARC) criteria
Time frame: 30 days
Event rate of Acute kidney injury
Time frame: 30 days
Event rate of Permanent pacemaker insertion
Time frame: 10 years
Event rate of Other TAVR-related complication
A. Conversion to open surgery B. Coronary obstruction C. Mitral valve apparatus damage or dysfunction D. Cardiac tamponade E. Endocarditis F. Valve thrombosis G. Valve mal-positioning H. TAV-in-TAV deployment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Bucheon Sejong Hospital
Bucheon-si, South Korea
ACTIVE_NOT_RECRUITINGChungnam National University Hospital
Daejeon, South Korea
RECRUITINGAsan Medical Center
Seoul, South Korea
RECRUITINGSeoul National University Hospital
Seoul, South Korea
COMPLETEDTime frame: 10 years
Event rate of Prosthetic valve dysfunction
according to Valve Academic Research Consortium (VARC) criteria A. Prosthetic aortic valve stenosis B. Prosthesis-patient mismatch C. Prosthetic aortic valve regurgitation
Time frame: 10 years
Event rate of Composite endpoint
A. Device success B. Early safety : death, cerebrovascular event, fatal bleeding, acute kidney injury, coronary obstruction requiring intervention, major vascular complication, valve dysfunction requiring intervention C. Clinical efficacy : death, cerebrovascular event, valve-related symptom requiring hospitalization or devastating heart failure, NYHA class\* III, IV dyspnea, valve dysfunction \*the New York Heart Association (NYHA) Functional Classification
Time frame: 10 years
Event rate of Structural valve deterioration
Time frame: 10 years
NYHA class
Time frame: 30 days
NYHA class
Time frame: 1 year
Valve area
Time frame: 1 year
Event rate of free from atrial fibrillation
Time frame: 10 years